Rettedal Elizabeth A, Ilesanmi-Oyelere Bolaji L, Roy Nicole C, Coad Jane, Kruger Marlena C
Food Nutrition & Health Team AgResearch Grasslands Palmerston North New Zealand.
Riddet Institute Massey University Palmerston North New Zealand.
JBMR Plus. 2021 Jan 19;5(3):e10452. doi: 10.1002/jbm4.10452. eCollection 2021 Mar.
Osteoporosis and its precursor osteopenia are common metabolic bone diseases in postmenopausal women. A growing body of evidence suggests that the gut microbiota is involved in the regulation of bone metabolism; however, there are few studies examining how gut microbiomes in osteoporosis and osteopenia may differ from those in healthy individuals. The aim of this study was to characterize the diversity, composition, and functional gene potential of the gut microbiota of healthy, osteopenic, and osteoporotic women. Body composition, bone density, and fecal metagenomes were analyzed in 86 postmenopausal women. The women were classified as healthy, osteopenic, or osteoporotic based on -scores. The taxonomic and functional gene compositions of the microbiome were analyzed using shotgun metagenomic sequencing. Both osteoporotic and osteopenic taxonomic compositions were found to be significantly different from healthy participants. Linear discriminant-analysis effect-size analyses identified that healthy participants had more unclassified and methanogenic archaea () than in both osteoporotic and osteopenic participants. was found to be more abundant in osteoporosis and osteopenia groups. Some KEGG pathways, including carbohydrate metabolism, biosynthesis of secondary metabolites, and cyanoamino acid metabolism, were found to be more abundant in both osteoporosis and osteopenia. These results show that osteoporosis and osteopenia alter the gut microbiome of postmenopausal women and identify potential microbial taxonomic and functional pathways that may be involved in this disease. © 2020 The Authors. published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
骨质疏松症及其前期状态骨质减少是绝经后女性常见的代谢性骨病。越来越多的证据表明,肠道微生物群参与骨代谢的调节;然而,很少有研究探讨骨质疏松症和骨质减少患者的肠道微生物群与健康个体的肠道微生物群有何不同。本研究的目的是描述健康、骨质减少和骨质疏松女性肠道微生物群的多样性、组成和功能基因潜力。对86名绝经后女性的身体成分、骨密度和粪便宏基因组进行了分析。根据T值将这些女性分为健康、骨质减少或骨质疏松组。使用鸟枪法宏基因组测序分析微生物群的分类和功能基因组成。发现骨质疏松组和骨质减少组的分类组成均与健康参与者有显著差异。线性判别分析效应大小分析确定,健康参与者比骨质疏松组和骨质减少组有更多未分类的和产甲烷古菌()。在骨质疏松症和骨质减少症组中发现更为丰富。一些KEGG途径,包括碳水化合物代谢、次生代谢物的生物合成和氰基氨基酸代谢,在骨质疏松症和骨质减少症中均更为丰富。这些结果表明,骨质疏松症和骨质减少症会改变绝经后女性的肠道微生物群,并确定了可能与这种疾病有关的潜在微生物分类和功能途径。©2020作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。